| 1 | [SID17389218] | Active | Potency | 0.1995 | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus: Cytotoxicity [AID931, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 0.1995 [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus: Cytotoxicity | | AID | 931 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 2 | [SID17389218] | Active | Potency | 1.58489 | Confirmation and Secondary Assays for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 and 705 loci [AID1405, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 1.58489 [uM] | | BioAssay | Confirmation and Secondary Assays for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 and 705 loci | | AID | 1405 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 3 | [SID17389218] | Active | Potency | 1.5849 | Cell Viability - LYMP1-003 - Assay at 40 hr [AID964, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | Cell Viability - LYMP1-003 - Assay at 40 hr | | AID | 964 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID17389218] | Active | Potency | 2.2387 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 5 | [SID17389218] | Active | Potency | 2.2387 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 6 | [SID17389218] | Active | Potency | 2.8695 | S16 Schwann cell PMP22 intronic element firefly luciferase assay [AID624032, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 2.8695 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element firefly luciferase assay | | AID | 624032 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 7 | [SID17389218] | Active | Potency | 3.1623 | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus [AID910, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus | | AID | 910 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 8 | [SID17389218] | Active | Potency | 3.1623 | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus [AID930, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus | | AID | 930 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 9 | [SID17389218] | Active | Potency | 10 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 10 | [SID17389218] | Active | Potency | 10 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 11 | [SID17389218] | Active | Potency | 10 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 12 | [SID17389218] | Active | Potency | 10 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 13 | [SID17389218] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 14 | [SID17389218] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 485290 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 15 | [SID17389218] | Active | Potency | 17.7693 | S16 Schwann cell PMP22 intronic element beta-lactamase assay [AID624044, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 17.7693 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element beta-lactamase assay | | AID | 624044 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 16 | [SID17389218] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 17 | [SID17389218] | Active | Potency | 23.7101 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 23.7101 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 18 | [SID17389218] | Active | Potency | 23.7101 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 23.7101 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 19 | [SID17389218] | Active | Potency | 23.7101 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 23.7101 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 20 | [SID17389218] | Active | Potency | 23.7101 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 23.7101 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 21 | [SID17389218] | Active | Potency | 42.1632 | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory] | interleukin 8 [Homo sapiens] [gi:186368] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 42.1632 [uM] | | BioAssay | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion | | AID | 651758 | | BioAssay type | confirmatory | | Target | interleukin 8 [Homo sapiens] [gi:186368] | | PubMed | | | Data Table |  |
|
| 22 | [SID17389218] | Active | Potency | 42.1632 | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory] | interleukin 8 [Homo sapiens] [gi:186368] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 42.1632 [uM] | | BioAssay | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion | | AID | 651758 | | BioAssay type | confirmatory | | Target | interleukin 8 [Homo sapiens] [gi:186368] | | PubMed | | | Data Table |  |
|
| 23 | [SID17389218] | Active | Potency | 42.1632 | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory] | interleukin 8 [Homo sapiens] [gi:186368] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | Potency | 42.1632 [uM] | | BioAssay | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion | | AID | 651758 | | BioAssay type | confirmatory | | Target | interleukin 8 [Homo sapiens] [gi:186368] | | PubMed | | | Data Table |  |
|
| 24 | [SID17389218] | Active | | | Cell Viability - SK-N-SH [AID435, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability - SK-N-SH | | AID | 435 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID17389218] | Active | | | Cell Viability - Hek293 [AID427, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability - Hek293 | | AID | 427 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID17389218] | Active | | | Cell Viability - Jurkat [AID426, Type: confirmatory] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability - Jurkat | | AID | 426 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID17389218] | Active | | | Cell Viability - BJ [AID421, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability - BJ | | AID | 421 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID17389218] | Active | | | Cell Viability - NIH 3T3 [AID541, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability - NIH 3T3 | | AID | 541 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID17389218] | Active | | | Cell Viability - H-4-II-E [AID543, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability - H-4-II-E | | AID | 543 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID17389218] | Active | | | Cell Viability - Mesenchymal [AID546, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability - Mesenchymal | | AID | 546 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID17389218] | Active | | | Cell Viability - HepG2 [AID433, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability - HepG2 | | AID | 433 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID17389218] | Active | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_30, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 33 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_8, Type: other] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_11, Type: other] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_12, Type: other] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_14, Type: other] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_19, Type: other] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_20, Type: other] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_23, Type: other] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_31, Type: other] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_29, Type: other] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_36, Type: other] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_54, Type: other] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_64, Type: other] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_69, Type: other] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_46, Type: other] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_73, Type: other] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_75, Type: other] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_76, Type: other] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID17389218] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_80, Type: other] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17389218 | | CID | 6537489 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|